Size of metabolically abnormal areas of myocardium · boys (aged 8 to 16 years old) with subclinical cardiomyopathy in DMD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Size of metabolically abnormal areas of myocardium · boys with DMD and left ventricular ejection fraction 45% or more
1 finding from 1 review
Size of metabolically abnormal areas of myocardium · boys with DMD, normal cardiac examination and LVEF > 55% at baseline
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Size of metabolically abnormal areas of myocardium · people with DMD or BMD (ages not stated)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Size of metabolically abnormal areas of myocardium · patients with established cardiomyopathy in DMD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abnormal FHR tracing · women with severe intrapartum fetal bradycardia
It is very uncertain whether summary of findings for IV atosiban changes abnormal FHR tracing compared with IV hexoprenaline (very low certainty).
1 finding from 1 review
Abnormal FHR tracing · women with a non‐reassuring fetal heart trace during labour but without uterine tachysystole
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abnormal FHR tracing · women who developed uterine hyperstimulation in labour with oxytocin augmentation, but without signs of fetal distress
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abnormal FHR tracing · women in labour with signs of fetal distress and a fetal scalp pH < 7.25, for whom the decision had been made for emergency delivery
Summary of findings for subcutaneous terbutaline probably leads to lower abnormal FHR tracing compared with no tocolytic agent, whilst awaiting emergency delivery (moderate certainty).
1 finding from 1 review
Abnormal FHR as defined by trial authors (FHR tracing not improved) · women with fetal distress for whom the decision had been made to delivery by emergency caesarean section
Summary of findings for selective ß2‐adrenergic agonist probably leads to lower abnormal FHR as defined by trial authors (FHR tracing not improved) compared with no tocolytic agent, whilst awaiting emergency delivery (moderate certainty).
1 finding from 1 review
Foetal abnormalities · Women undergoing IVF/ICSI cycles
1 finding from 1 review
Uterine tachysystole combined with abnormal fetal heart rate · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation probably leads to lower uterine tachysystole combined with abnormal fetal heart rate compared with continued IV oxytocin stimulation (moderate certainty).
1 finding from 1 review
Intrapartum cardiotocography (CTG) abnormalities (suspicious/pathological CTGs) · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation probably leads to lower intrapartum cardiotocography (CTG) abnormalities… compared with continued IV oxytocin stimulation (moderate certainty).
1 finding from 1 review
Adverse effects Local or systemic inflammatory response, cardiovascular abnormalities, and thromboembolic complications · patients with Buerger's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Abnormally large livers reduced to within normal limits, as measured by ultrasound · adults and children with cystic fibrosis‐related liver disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Improved abnormal biliary excretion · adults and children with cystic fibrosis‐related liver disease
1 finding from 1 review
Adverse effects Mild abdominal pain and nausea Adverse effects Mild abnormal liver function · patients with Old World cutaneous leishmaniasis
It is very uncertain whether itraconazole (200 mg for 6 to 8 weeks) changes adverse effects Mild abdominal pain and nausea Adverse effects Mild… compared with placebo (very low certainty).
1 finding from 1 review
Abnormal dreams · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine led to higher abnormal dreams compared with doxycycline; GRADE not reported.
1 finding from 1 review
Abnormal thoughts or perceptions · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine showed no clear difference in abnormal thoughts or perceptions compared with doxycycline; GRADE not reported.
1 finding from 1 review
Abnormal dreams · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine led to higher abnormal dreams compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review